Moneycontrol PRO
HomeNewsLincolnpharmaceuticals

At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

Jump to
  • Expect growth to continue going forward: Lincoln Pharma

    Expect growth to continue going forward: Lincoln Pharma

    In an interview to CNBC-TV18, Mahendra Patel, MD of Lincoln Pharmaceuticals spoke about the results and his outlook for the company.

  • See FY12 revenues at Rs 170-175 crore: Lincoln Pharma

    See FY12 revenues at Rs 170-175 crore: Lincoln Pharma

    Lincoln Pharma has had a down day in the trade, after the operating performance of the company has slipped in Q3. In an exclusive interview with CNBC-TV18’s Reema Tendulkar and Ekta Batra, Mahendra Patel, Managing Director of Lincoln Pharma says that the company is hopeful to earn revenues worth Rs 170 crore to Rs 175 crore.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347